Status:

UNKNOWN

Effect of Maternal BMI and Type of Infants Feeding on IGF-1 in Infant

Lead Sponsor:

Assiut University

Conditions:

IGF1 Deficiency

Eligibility:

All Genders

2-3 years

Phase:

NA

Brief Summary

IGF-I is a mitogenic and antiapoptotic. paracrine growth factor expressed in all fetal organ. and is essential in fetal and neonatal growth, differentiation and development Several lines of evidence s...

Detailed Description

For healthy mother ,breastfeeding represent the gold standard for infant health, and infant formula development aims at mimicking the physiological response to human milk intake. while protein content...

Eligibility Criteria

Inclusion

  • infants from two to three month and thier mother

Exclusion

  • 1 -VLBW. 2-preterm infants. 3-IUGR 4-mother with hormonal disturbance

Key Trial Info

Start Date :

December 1 2017

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 1 2018

Estimated Enrollment :

40 Patients enrolled

Trial Details

Trial ID

NCT03275272

Start Date

December 1 2017

End Date

December 1 2018

Last Update

September 7 2017

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.